Hilmar M. Warenius

799 total citations
48 papers, 655 citations indexed

About

Hilmar M. Warenius is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hilmar M. Warenius has authored 48 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Molecular Biology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hilmar M. Warenius's work include Radiation Therapy and Dosimetry (11 papers), Cancer-related Molecular Pathways (10 papers) and Advanced Radiotherapy Techniques (6 papers). Hilmar M. Warenius is often cited by papers focused on Radiation Therapy and Dosimetry (11 papers), Cancer-related Molecular Pathways (10 papers) and Advanced Radiotherapy Techniques (6 papers). Hilmar M. Warenius collaborates with scholars based in United Kingdom, United States and Australia. Hilmar M. Warenius's co-authors include Richard A. Britten, John A. Green, John H. Peacock, J.H. Peacock, Peter S. Friedmann, C. C. Thompson, N M Bleehen, David G. Spiller, Matthew D. Jones and David Husband and has published in prestigious journals such as Journal of Cell Science, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hilmar M. Warenius

46 papers receiving 632 citations

Peers

Countries citing papers authored by Hilmar M. Warenius

Since Specialization

Citations

This map shows the geographic impact of Hilmar M. Warenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilmar M. Warenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilmar M. Warenius more than expected).

Fields of papers citing papers by Hilmar M. Warenius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilmar M. Warenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilmar M. Warenius. The network helps show where Hilmar M. Warenius may publish in the future.

Co-authorship network of co-authors of Hilmar M. Warenius

This figure shows the co-authorship network connecting the top 25 collaborators of Hilmar M. Warenius. A scholar is included among the top collaborators of Hilmar M. Warenius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilmar M. Warenius. Hilmar M. Warenius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4 2011 ·Molecular Cancer ·Hilmar M. Warenius, Jeremy Kilburn, (unknown), Richard I. Maurer, Jeremy P. Blaydes, (unknown), (unknown)	19
2	Spontaneous regression of human cancer cells in vitro: potential role of disruption of Cdk1/Cdk4 co-expression. 2009 ·PubMed ·Hilmar M. Warenius, (unknown), Ian Grierson, (unknown), (unknown), Mark Jones, Carole D. Thomas, (unknown), (unknown)	6
3	Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells 2007 ·European Journal of Cancer ·(unknown), Hilmar M. Warenius	5
4	Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity 2000 ·British Journal of Cancer ·Hilmar M. Warenius, Matthew D. Jones, Tracy Gorman, (unknown), (unknown), Roger Barraclough, (unknown)	19
5	The Influence of Hypoxia on the Relative Sensitivity of Human Tumor Cells to 62.5 MeV (p→Be) Fast Neutrons and 4 MeV Photons 2000 ·Radiation Research ·Hilmar M. Warenius, (unknown), John H. Peacock, John Hanson, Richard A. Britten, David Murray	8
6	Sensitivity to cis-diamminedichloroplatinum in human cancer cells is related to expression of cyclin D1 but not C-RAF-1 protein 1996 ·International Journal of Cancer ·Hilmar M. Warenius, (unknown), (unknown)	39
7	An electronic study guide for problem‐based learning 1995 ·Medical Education ·(unknown), John Bligh, Sam Leinster, Hilmar M. Warenius	10
8	Fast Neutron Therapy: The UK experience 1994 ·Acta Oncologica ·Hilmar M. Warenius	2
9	Identification of human in vitro cell lines with greater intrinsic cellular radiosensitivity to 62.5 MeV (p → Be+) neutrons than 4 MeV photons 1994 ·International Journal of Radiation OncologyBiologyPhysics ·Hilmar M. Warenius, Richard A. Britten, (unknown), (unknown), John H. Peacock	18
10	In Vitro Studies of Intrinsic Cellular Radiosensitivity Following 4 MeV Photons or 62.5 MeV (p⇒ Be⁺) Neutrons: Potential implications for high LET therapy 1994 ·Acta Oncologica ·Hilmar M. Warenius, Richard A. Britten	7
11	Alteration of cellular immune responses by nutrition and weaning in calves 1993 ·Research in Veterinary Science ·J.M. Pollock, T.G. Rowan, John B. Dixon, Stuart Carter, David G. Spiller, Hilmar M. Warenius	22
12	The differential induction of collateral resistance to 62.5 MeV (p→Be+) neutrons and 4 MeV photons by exposure to cis-platinum 1993 ·International Journal of Radiation OncologyBiologyPhysics ·Richard A. Britten, Hilmar M. Warenius, John R. Masters, John H. Peacock	13
13	Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumour cells 1992 ·Radiotherapy and Oncology ·Richard A. Britten, J.H. Peacock, Hilmar M. Warenius	15
14	The Inherent Cellular Sensitivity to 62·5 MeV_(p→Be⁺)Neutrons of Human Cells Differing in Photon Sensitivity 1992 ·International Journal of Radiation Biology ·Richard A. Britten, Hilmar M. Warenius, C.S. Parkins, J.H. Peacock	20
15	Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Richard A. Britten, John A. Green, Hilmar M. Warenius	65
16	Melphalan resistant human ovarian tumour cells are cross-resistant to photons, but not to high LET neutrons 1990 ·Radiotherapy and Oncology ·Richard A. Britten, Hilmar M. Warenius, (unknown), (unknown), (unknown)	20
17	Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma 1989 ·Cancer Chemotherapy and Pharmacology ·John A. Green, R. Douglas Errington, (unknown), (unknown), Hilmar M. Warenius	0
18	Ifosfamide encephalopathy: a reappraisal 1989 ·European Journal of Cancer and Clinical Oncology ·(unknown), David Husband, John A. Green, Hilmar M. Warenius	36
19	Sequential chemotherapy, surgery and radiotherapy in locally advanced breast cancer 1988 ·Clinical Radiology ·Ian R. Campbell, (unknown), R.D. Errington, Sam Leinster, Swe Swe Myint, Hilmar M. Warenius	4
20	³¹P NMR studies on recovery from hypoxia of human tumor cells 1987 ·Magnetic Resonance in Medicine ·(unknown), Albert E. Smith, Swe Swe Myint, (unknown), Raymond J. Abraham, R. H. T. Edwards, Hilmar M. Warenius	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact